Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Preoperative Sedation in Children
NCT05111431Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Nov 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in preoperative anxiety, sponsored by Hengrui Therapeutics. Started Nov 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on NCT05111431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05111431.